SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
--------------------------------------------------------------------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported):  August 13, 2003
                                                   ---------------


                         Bio-Imaging Technologies, Inc.
                         ------------------------------
               (Exact Name of Registrant as Specified in Charter)


        Delaware                       1-11182                   11-2872047
--------------------------------------------------------------------------------
(State or Other Jurisdiction   (Commission File Number)        (IRS Employer
     of Incorporation)                                       Identification No.)



826 Newtown-Yardley Road, Newtown, PA                                  18940
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                            (Zip Code)


                                 (267) 757-3000
                                 --------------
                        (Registrant's telephone number,
                              including area code)



              ----------------------------------------------------
         (Former Name or Former Address, if Changed Since Last Report)




ITEM 9.  REGULATION FD DISCLOSURE  (INFORMATION  FURNISHED  PURSUANT TO ITEM 12,
         "DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION").

     On  August  13,  2003,  Bio-Imaging  Technologies,   Inc.  (the  "Company")
announced  its financial  results for the quarter ended June 30, 2003.  The full
text of the press release issued in connection with the announcement is attached
as Exhibit 99.1 to this Current Report on Form 8-K.

     In accordance with the procedural  guidance in SEC Release Nos. 33-8216 and
34-47583,  the  information in this Form 8-K and the Exhibit  attached hereto is
being furnished under "Item 9. Regulation FD Disclosure" rather than under "Item
12.   Disclosure  of  Results  of  Operations  and  Financial   Condition."  The
information  shall not be deemed  "filed"  for  purposes  of  Section  18 of the
Securities  Exchange Act of 1934, as amended (the "Exchange  Act"), or otherwise
subject to the liabilities of that section,  nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended,  or the
Exchange  Act,  except as  expressly  set forth by specific  reference in such a
filing.




                                      - 2 -


                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.



                                BIO-IMAGING TECHNOLOGIES, INC.



Dated: August 13, 2003          By: /s/ Mark L. Weinstein
                                   ---------------------------------------------
                                    Name:  Mark L. Weinstein
                                    Title: President and Chief Executive Officer






                                  EXHIBIT INDEX


Exhibit No.            Description
-----------            -----------

99.1                   Press release dated August 13, 2003.